業 績

論 文

  • Ihara, F., Sakurai, D., Horinaka, A., Fujisawa, A., Makita, Y., Sakurai, T., Yamasaki, K., Kunii, N., Motohashi, S., Nakayama, T. and Okamoto, Y. : CD45RA-Foxp3high regulatory T cells have a negative impact on the clinical outcome of head and neck squamous cell carcinoma. Cancer Immunol Immunother. 66(10):1275-85(2017).
  • Hosokawa, H., Tanaka, T., Endo, Y., Kato, M., Shinoda, K., Suzuki, A., Motohashi, S., Matsumoto, M., Nakayama, K. I. and Nakayama, T. : Akt1-mediated Gata3 phosphorylation controls the repression of IFNγ in memory-type Th2 cells. Nat Commun. 7:11289 (2016).
  • Mise, N., Takami, M., Suzuki, A., Kamata, T., Harada, K., Hishiki, T., Saito, T., Terui, K., Mitsunaga, T., Nakata, M., Ikeuchi, T., Nakayama, T., Yoshida, H. and Motohashi, S. : Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant NKT cells. Cancer Sci. 107(3):233-41 (2016).
  • Uchida, M., Suzuki, S., Suzuki, T. and Ishii, I. : p27(Kip1) and p21(Cip1)-independent proliferative inhibition of vascular smooth muscle cells cultured in type-I collagen matrix honeycombs. Microvasc Res. 103:36-40 (2016).
  • Hirahara, K. and Nakayama, T. : CD4+ T cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. Int Immunol. 28(4):163-71 (2016).
  • Frigault, M. J., Lee, J., Basil, M., Carpenito, C., Motohashi, S., Scholler, J., Kawalekar, O. U., Guedan, S., McGettigan, S., Posey, A Jr., Ang, S., Cooper, L. J., Platt, J., Johnson, F. B., Paulos, C. M., Zhao, Y., Kalos, M., Milone, M. and June, C. H. : Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells. Cancer Immunol Res. 3(4):356-367 (2015).
  • Ishii, I. and Uchida, M. : Three-Dimensional “Honeycomb” Culture System that Helps to Maintain the Contractile Phenotype of Vascular Smooth Muscle Cells. Muscle Cell and Tissue", book edited by Kunihiro Sakuma, ISBN 978-953-51-2156-5 (2015).
  • Matsumoto, J., Ariyoshi, N., Sakakibara, M., Nakanishi, T., Okubo, Y., Shiina, N., Fujisaki, K., Nagashima, T., Nakanishi, Y., Tamai, I., Yamada, H., Takeda, H. and Ishii, I. : Organic anion transporting polypeptide 2B1 expression vcorrelates with uptake of estrone-3-sulfate and cell proliferation in estrogen receptor-positive breast cancer cells. Drug Metab Pharmacokinet. 30(2):133-41 (2015).
  • Hirahara, K., Onodera, A., Villario, AV., Bonelli, M., Sciumè, G., Laurence, A., Sun, HW., Brooks, RS., Vahedi, G., Shih, HY., Gutierrez-Cruz, G., Iwata, S., Suzuki, R., Miami, Y., Okamoto, Y., Wakayama, T., Holland, S., Hunter, CA., Kanno, Y. and O’Shea, JJ. : Asymmetric action of STAT transcription factors drives transcriptional outputs and cytokine specificity. Immunity. 42(5):877-89 (2015).
  • Horinaka, A., Sakurai, D., Ihara, F., Makita, Y., Kunii, N., Motohashi, S., Nakayama, T. and Okamoto, Y. : Invariant NKT cells are resistant to circulating CD15+ myeloid-derived suppressor cells in patients with head and neck cancer. Cancer Sci. 107(3):207-16 (2015).
  • Miasma, S., Sato, Y., Katayama, K., et al. : Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study. BMJ Open. 5(11):e009157 (2015).
  • Katayama, K., Misawa, S., Sato, Y., et al. : Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open. 5(1):e007330 (2015).
PageTop